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Nanocomposite Scaffold for Chondrocyte
Growth and Cartilage Tissue Engineering:
Effects of Carbon Nanotube Surface Functionalization
Nadeen O. Chahine, PhD,1 Nicole M. Collette, PhD,2 Cynthia B. Thomas,2
Damian C. Genetos, PhD,3 and Gabriela G. Loots, PhD2,4
The goal of this study was to assess the long-term biocompatibility of single-wall carbon nanotubes (SWNTs)
for tissue engineering of articular cartilage. We hypothesized that SWNT nanocomposite scaffolds in cartilage
tissue engineering can provide an improved molecular-sized substrate for stimulation of chondrocyte growth, as
well as structural reinforcement of the scaffold’s mechanical properties. The effect of SWNT surface func-
tionalization (-COOH or -PEG) on chondrocyte viability and biochemical matrix deposition was examined in
two-dimensional cultures, in three-dimensional (3D) pellet cultures, and in a 3D nanocomposite scaffold
consisting of hydrogels+SWNTs. Outcome measures included cell viability, histological and SEM evaluation,
GAG biochemical content, compressive and tensile biomechanical properties, and gene expression quantifi-
cation, including extracellular matrix (ECM) markers aggrecan (Agc), collagen-1 (Col1a1), collagen-2
(Col2a1), collagen-10 (Col10a1), surface adhesion proteins fibronectin (Fn), CD44 antigen (CD44), and tumor
marker (Tp53). Our findings indicate that chondrocytes tolerate functionalized SWNTs well, with minimal
toxicity of cells in 3D culture systems (pellet and nanocomposite constructs). Both SWNT-PEG and SWNT-
COOH groups increased the GAG content in nanocomposites relative to control. The compressive biome-
chanical properties of cell-laden SWNT-COOH nanocomposites were significantly elevated relative to control.
Increases in the tensile modulus and ultimate stress were observed, indicative of a tensile reinforcement of the
nanocomposite scaffolds. Surface coating of SWNTs with -COOH also resulted in increased Col2a1 and Fn
gene expression throughout the culture in nanocomposite constructs, indicative of increased chondrocyte
metabolic activity. In contrast, surface coating of SWNTs with a neutral -PEG moiety had no significant effect
on Col2a1 or Fn gene expression, suggesting that the charged nature of the -COOH surface functionalization
may promote ECM expression in this culture system. The results of this study indicate that SWNTs exhibit a
unique potential for cartilage tissue engineering, where functionalization with bioactive molecules may provide
an improved substrate for stimulation of cellular growth and repair.
Introduction
Advances in biomaterial development and applica-tions are critical for the continued improvement of
regenerative medicine technologies aimed at repairing mus-
culoskeletal damage.1–3 Carbon nanotubes are an attractive
component of tissue engineering materials, specifically for
controlling the production or delivery of tissue-inducing
substances such as growth factors, peptides, or DNA.4,5
Single-wall carbon nanotubes (SWNTs) are rolled cylin-
drical tubes of carbon atoms that can be tens of microns in
length and as small as 1–2 nm in diameter. SWNTs possess
unique mechanical and physical properties for studying
cell–material interactions such as surface functionalization,
structural flexibility, and the ability to interact with or
penetrate into cell membranes.6
A common strategy in tissue engineering is surface func-
tionalization, where the surface of a nanomaterial is chem-
ically modified, adding functional groups that enhance
the physical or biological performance of the material.
SWNTs are inherently hydrophobic when utilized in the as-
produced form, a condition that can be overcome with
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surface functionalization. Acid reflux of SWNTs and other
nanotubes has been widely used to attach carboxyl groups to
their surfaces (e.g., SWNT-COOH).7–10 These carboxylated
nanotubes can be further derivatized to covalently link the
SWNTs with other polymers (e.g., PEG), effectively in-
creasing their solubility and biocompatibility.7–9
Many biomaterials have been used for cartilage tissue
engineering applications, as previously summarized.2,3,11,12
Whereas hydrogels are an attractive option because of their
biocompatibility, capacity to incorporate chemical cues, and
innate hydrated structure, their mechanical properties are
often inferior to that of native cartilage. Fiber-reinforced
biomaterials, such as woven and electrospun scaffolds, have
been developed and possess biomechanical properties more
similar to those of native tissues.13–17 Mechanical rein-
forcement of gels with nanotubes has also been examined in
tissue engineering of bone,18–21 although not in cartilage
engineering applications. We hypothesized that SWNT na-
nocomposite scaffolds in cartilage tissue engineering can
provide an improved molecular-sized substrate for stimu-
lation of cellular growth, as well as structural reinforcement
of the scaffold’s mechanical properties.
The goal of this study was to assess the long-term bio-
compatibility of SWNTs for chondrocyte growth and tissue
engineering of articular cartilage. The effects of SWNTs
on chondrocytes were examined in two-dimensional (2D)
cultures, in three-dimensional (3D) pellet cultures, and in
nanocomposite scaffolds consisting of hydrogels + SWNTs.
We examined the effects of SWNT surface functionaliza-
tion with polyethlyne glycol (-PEG) or carboxyl groups
(-COOH) on chondrocyte growth. We hypothesized that
chemical surface functionalization with -COOH will pro-
mote cartilaginous matrix expression and deposition to a
greater level than -PEG functionalization, resulting in a
biomimetic microenvironment for enhanced cartilage re-
generation. Gene expression of extracellular matrix (ECM)
markers, surface adhesion proteins (fibronectin, CD44) that
mediate cell–matrix interactions,22–24 and tumor marker
(Tp53) were examined in this culture system. Our findings
indicate that SWNT-COOH promotes the expression of
ECM proteins and the biomechanical properties of cell-
laden nanocomposite scaffolds grown over 5 weeks in
culture, in a mechanism potentially mediated by increased
surface adhesion protein expression in SWNT nano-
composite scaffolds.
Materials and Methods
Purified SWNTs functionalized with terminal carboxylic
acid (SWNT-COOH) or covalent polyethylene glycol
(SWNT-PEG) (Carbon Solutions, Inc.) were UV-sterilized,
suspended in DI water, and sonicated for *3 h to arrive at
a stable, homogenous suspension at room temperature.
Chondrocytes were isolated from juvenile (1–3 days old)
bovine knee articular cartilage from local abattoirs. Full-
thickness cartilage was dissected from the femoral condyles,
and digested in complete media (DMEM, 4.5 g/L D-Glucose,
110 mg/L sodium pyruvate (Gibco)+ 10% FBS+ 1% antibi-
otic/antimycotic [Gibco]) supplemented with pronase (2 mg/
mL; Sigma, 1 h), then collagenase type-IA (0.5 mg/mL; Sig-
ma, 4 h) at 37C. The resulting cell suspension was filtered
through 70-mm cell strainers (BD).
Two-dimensional culture
Primary chondrocytes were plated in high-confluence
culture (1· 106 cells/cm2) to minimize cell spreading and
dedifferentiation in 96-well plates, and cultured in
DMEM + 10% FBS + 1· penicillin/streptomycin up to 14
days. Cells were exposed to fresh media (3· weekly) con-
taining one of the following treatments: (1) Control, (2)
Sonicated Media (SM), (3) 0.1 mg/mL SWNT-COOH, (4)
0.01 mg/mL SWNT-COOH, (5) 0.1 mg/mL SWNT-PEG,
and (6) 0.01 mg/mL SWNT-PEG. Chondrocyte viability was
determined by Live/Dead fluorescence microplate assay
(Molecular Probes), at days 0, 3, 7, and 14, and reported
as% live cells, according to the manufacturer’s protocol.
Percentage viability (% live cells) in SWNT groups was
determined by analysis of viability in each well relative to a
corresponding killed group. Cells in one well per group were
treated with 0.25% digitonin to measure viability in the
killed group. Percentage viability is reported normalized to
an untreated control group.
Pellet culture
Primary chondrocytes were grown in micromass cul-
tures –SWNTs at the same concentrations (0.01 and 0.1 mg/
mL) and surface functionalization (SWNT-PEG and SWNT-
COOH) as described in 2D culture above. Mixtures of
chondrocytes (2· 105) and SWNTs in suspension were
centrifuged to create a pellet. All pellets were cultured in
chondrogenic media (high glucose DMEM supplemented
with 10 ng/mL TGF-b3, 0.1 mM dexamethasone, 40 mg/mL
L-proline, 100mg/mL sodium pyruvate, 1· insulin- trans-
ferrin-selenous acid, and 1· penicillin/streptomycin) in 5%
CO2 and 37C. Fresh media were replaced every 3 days, and
pellets were maintained in culture for up to 14 days.
Hydrogel cultures
SWNT solutions were added to molten agarose (Type
VII; Sigma Aldrich), and the mixtures were sonicated for
30 min. Primary chondrocytes in suspension were mixed
with the agarose/SWNT and cast between two glass plates.
The mixture was allowed to gel at room temperature for
20 min and cylindrical disks (ø5 mm/*1.7 mm thick) were
then prepared using a biopsy punch. Cylindrical constructs
were prepared from three treatment groups: (1) Control (no
SWNTs), (2) 0.1 mg/mL SWNT-PEG, and (3) 0.1 mg/mL
SWNT-COOH, with a final cell seeding density of 10· 106
cells/mL and 2% agarose content. Disks were cultured in
chondrogenic media for up to 35 days.
Gene expression
Gene expression of ECM genes (aggrecan, collagen-1,
collagen-2, and collagen-10), surface adhesion proteins (fi-
bronectin, CD44), and tumor marker (p53) levels was deter-
mined by quantitative RT-PCR from chondrocytes cultured in
hydrogel nanocomposite scaffolds. Total RNA was isolated
from hydrogel nanocomposite constructs using the RNEasy
kit (Qiagen), where the lysis buffer was supplemented with
b-mercaptoethanol (1%) and 2M sodium acetate (0.66%).
Homogenization was performed with QIAShredder (Qiagen)
according to the manufacturer’s protocol. About 0.5–1mg of
RNA was reverse-transcribed into cDNA using the
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QuantiTect Reverse Transcription kit (Qiagen), which in-
cludes genomic DNA elimination. Proprietary primer and
TaqMan(TM) probe sets were purchased from Applied Bio-
systems (Bt03212196_m1, Agc1; Bt03225343_g1, Col1a1;
Bt03251852_m1, Col2a1; Bt03215581_m1, Col10a1;
Bt03223217_mL, Tp53; Bt00415008_mL, Fn1; Bt03211311_
g1, Vtn; Bt03212356_m1, CD44; and Bt03224615_g1, Pp1a).
qPCR cycling conditions were 95C for 3 min, followed by
40 cycles of 95C for 3 s, then 30 s at 60C. qPCR results
were calculated relative to internal control cyclophilin
(Pp1a) using the 2 -DCt method.25
Histology
Pellets and agarose disks were fixed in 10% buffered
formalin and then processed for standard paraffin embed-
ding, sectioning (10 mm), and staining. Sections were stained
with Alcian blue (proteoglycan) or Picrosirius red (colla-
gen). Sample images were acquired with a Leica DM5000B
light microscope and ImageProPlus software.
Scanning electron microscopy
Samples were rinsed in the serum-free DMEM and fixed
with 2% glutaraldehyde in a 0.1 M cacodlyate buffer. Sam-
ples were dehydrated with serial ethanol washes, treated in a
critical point dryer, mounted for sputter coating (gold), and
imaged with a Hitachi S800 scanning electron microscope.
Biomechanical characterization
The biomechanical properties of cylindrical constructs
(n = 3–4) were measured under unconfined compres-
sion using an Instron testing frame (equipped with 50N
load cell). Samples were tested in a PBS bath where three
stress relaxation compressions were applied (5% strain per
ramp), and the Young’s modulus (EY) was determined as
the slope of the stress–strain curve obtained at equilibrium
after each ramp. The dynamic modulus (G*) was computed
as the ratio of peak stress to peak strain during cyclic
loading applied at 0.1 Hz, and averaged over five loading
cycles. Samples were preserved at - 20C after mechanical
testing and utilized for biochemical content measure-
ments. Tensile properties of acellular hydrogel – 0.1 mg/
mL SWNT-COOH were measured at 25C on dog-bone
shaped tensile samples (12 mm wide · 2.4 mm thick · 60
mm gauge length, n = 4). Samples were clamped between 2
hydraulic tensile grips with 200 grit sand paper used at
interface to prevent slipping. Sample dimensions were
measured with digital calipers, and samples were moist-
ened with PBS during the tensile test. Samples were loaded
in uniaxial tension at the rate of 0.15 mm/s until failure.
The ramp tensile modulus was calculated from the linear
region of the stress–strain curve. Tensile failure strain
and ultimate stress (maximum stress) and toughness (in-
tegrated area under the stress–strain curve) were calculated
for each sample.
Biochemistry
Agarose samples (n = 5–8) were thawed, weighed wet,
and lyophilized overnight. Sample dry weight was col-
lected and samples were digested overnight at 60C in 2%
papain (Sigma Aldrich) in a buffer composed of 0.1 M
sodium acetate, 0.05 M EDTA, and 10 mM Cystine HCL.
The glycosaminoglycan (GAG) content in the sample di-
gest was measured using the Blyscan assay, according to
the manufacturer’s protocol against a standard of chon-
droitin-4 sulfate. The GAG content is reported as % of
tissue wet weight.
Statistical analysis
Statistical analysis was performed using STATISTICA
(StatSoft, Inc.), unless otherwise noted. Cellular viability in
2D culture was analyzed with 2-way ANOVA, with culture
duration and treatment groups taken as independent vari-
ables, and the HSD post hoc test. The GAG content of na-
nocomposite scaffolds was analyzed with 2-way ANOVA,
with culture duration and SWNT functionalization as inde-
pendent variables, and the unequal N HSD post hoc test.
Compressive biomechanical properties were analyzed with
2-way ANOVA and the LSD post hoc test. The tensile
properties of acellular nanocomposite scaffolds were ana-
lyzed with a t-test using Excel. qPCR results were analyzed
by 2-way ANOVA and the Sidak multiple comparisons test
using GraphdPad Prism. Significance was considered for
p < 0.05.
Results
In 2D cultures, chondrocytes maintained comparable vi-
ability in all groups up to day 3 (D3) (Fig. 1). Cells cultured
in SM resulted in a minor loss of viability, demonstrating
82%– 18% viability at D14 ( p > 0.3). The addition of
SWNTs at 0.01 mg/mL did not significantly alter cell via-
bility over the course of the experiment, and chondrocytes
exhibited comparable viability for both surface functiona-
lization at D14 (SWNT-PEG: 83% – 6%; SWNT-COOH:
76%– 9%; p > 0.8). At the higher concentration of SWNT
(0.1 mg/mL), cell viability decreased significantly between
D3 and D7, such that 45%– 13% ( p < 0.001) and 22%– 8%
( p< 0.001) of cells were viable in the presence of SWNT-
PEG and SWNT-COOH, respectively (Fig. 1). By D14, no
additional loss of cells was seen for either functional group
at 0.1 mg/mL ( p > 0.5). The viability of chondrocytes cul-
tured in the 0.1 mg/mL SWNT groups was significantly
lower than their respective surface functionalization groups
at 0.01 mg/mL at both D7 and D14 (SWNT-PEG: p < 0.01,
SWNT-COOH: p < 0.0005, Fig. 1). No significant difference
was observed between the 0.01 mg/mL SWNT groups and
SM groups.
Cells – SWNTs cultured in pellet cultures were analyzed
for biochemical deposition of GAG and collagen using
standard histological analyses. At D14, control pellets
exhibited dense deposition of sulfated GAG and collagen
(Fig. 2). Alcian blue staining of pellets cultured with
SWNTs exhibited increased cell density relative to control
at both 0.01 and 0.1 mg/mL concentrations, although the
GAG staining intensity across groups was comparable (Fig.
2). Sections of pellets cultured with SWNT-PEG at both
0.01 and 0.1 mg/mL concentrations exhibited decreased
Picrosirius red staining relative to the control group (Fig.
2), indicative of lower collagen deposition. Cell pellets
cultured with 0.1 mg/mL SWNT-COOH exhibited com-
parable collagen deposition relative to control, although
the 0.01 mg/mL SWNT-COOH group appeared to have
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lower collagen deposition than control (Fig. 2). SEM
analysis demonstrated comparable cell morphology in
pellets cultured – SWNTs (Fig. 2).
Based on the deposition of a cartilaginous ECM in chon-
drocyte pellets cultured in 0.1 mg/mL SWNTs, we created
nanocomposite constructs of agarose hydrogel– SWNTs
seeded with chondrocytes at this concentration. Mor-
phology and viability of chondrocytes in SWNT nano-
composite constructs were evaluated (Fig. 3). At D7 in
culture, chondrocytes exhibited high viability in SWNT-
COOH and SWNT-PEG nanocomposites that was similar
to the viability exhibited in the controls (Fig. 3). In ad-
dition, the DNA content of chondrocytes cultured in na-
nocomposites was found to be similar to or greater than
that measured in the control group up to D35 (data not
shown), further suggesting that functionalization pro-
moted cellular growth.
Time-dependent analyses of the gene expression of
chondrocytes cultured in nanocomposite constructs were
performed using qPCR. Aggrecan (Agc1) expression, an
integral component of cartilage ECM, was transient,
reaching peak expression at D14 and D21 in culture in
control samples. At D14 and D21, Agc1 expression was
significantly diminished in the SWNT-PEG group relative
to control ( p < 0.05 and p < 0.01, respectively, Fig. 4). No
significant differences in Agc1 expression were observed
between control and SWNT-COOH groups. Collagen-2
(Col2a1) expression, the primary collagen found in ar-
ticular cartilage ECM, was significantly elevated at
D14, D28, and D35 in SWNT-COOH relative to control
( p < 0.05), with no significant upregulation observed in the
SWNT-PEG group. Collagen-10 (Col10a1), a marker of
chondrocyte hypertrophy, expression diminished with time
in culture across all groups, with SWNT-COOH exhibiting
elevated expression relative to control at early time points
(D0 and D7, p < 0.001). No significant differences were
seen in Col10a1 expression between groups at other time
points. Expression of collagen-1 (Col1a1), a marker of
dedifferentiation of chondrogenic phenotype, increased
slightly over time in culture in all groups, although these
increases were not statistically different between groups
( p > 0.05; Fig. 4). The expression of two surface adhesion
proteins, fibronectin (Fn1) and CD44 antigen (CD44), was
assessed in the SWNT composite samples over time in
culture. Chondrocytes cultured in SWNT-COOH exhibited
significantly elevated Fn1 expression at multiple time
points (D7 and D28, p < 0.01) in -COOH groups, while at
D14, Fn1 expression in SWNT-PEG was significantly
greater than in control ( p < 0.05). CD44 expression in-
creased over time in culture in all groups between D14 and
D35, although levels of CD44 were greatest in the control
group (Fig. 4). CD44 expression levels in both SWNT
groups were significantly lower than in the control group at
D28 and D35 ( p < 0.01, Fig. 4). Expression for the tumor
marker Tp53 was found to be unchanged among groups
over the duration of the culture (Fig. 4), suggesting that the
presence of SWNTs is not likely to promote oncogenic
transformation.
The GAG biochemical content of SWNT hydrogel
composites was also assessed (Fig. 5A). The GAG con-
tent significantly increased in culture up to D28 and D35
in control and SWNT groups, respectively (Fig. 5A,
p < 0.001). The SWNT-COOH group exhibited a signifi-
cantly higher GAG content relative to controls on D21,
D28, and D35 ( p < 0.001). The GAG content in the SWNT-
PEG group was significantly greater than in the control
FIG. 1. (A) Time-dependent viability (%
live cells) of chondrocytes in 2D culture
after 3, 7, or 14 days of coculture with
functionalized SWNTs (-COOH or -PEG) at
0.01 or 0.1 mg/mL (n = 5 per group;
*p < 0.05 versus SM and 0.1 mg/mL group
of corresponding functionalization, within
time point. ^p < 0.05 versus D3 within
group). (B-G) Representative live (green)
images of chondrocytes in 2D culture at D7
(scale bar= 40 mm). 2D, two-dimensional;
SWNTs, single-wall carbon nanotubes.
Color images available online at www
.liebertpub.com/tea
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group at D28 and D35 ( p < 0.01). At D21, the GAG con-
tent of SWNT-COOH group was significantly greater than
the SWNT-PEG group ( p < 0.001, Fig. 5A).
Significant temporal increases in the compressive bio-
mechanical properties of the controls and SWNT-COOH
composites were exhibited over time in culture ( p < 0.03;
Fig. 5B). EY increased to 30 – 10 kPa by D21 in the control
group ( p < 0.05 vs. D0). The presence of 0.1 mg/mL
SWNT-COOH increased EY by 78%, reaching 53 – 8 kPa
at D21 ( p < 0.05 vs. D0). The presence of SWNT-PEG
demonstrated transient effects on EY, with no significant
increases over control (Fig. 5A). The dynamic modulus,
G*, of samples in the SWNT-COOH group was found to
increase by 37% and 48% relative to control groups at D21
and D35, respectively (D21; control: 0.25 – 0.08 MPa,
SWNT-COOH: 0.36 – 0.11 MPa, p < 0.005). The tensile
properties of acellular agarose-SWNT composites were
measured. The addition of 0.1 mg/mL SWNT-COOH in-
creased the tensile modulus by *30% ( p < 0.001) and
increased the ultimate stress by *40% ( p < 0.05, Table 1).
No significant differences in the tensile failure strain or
toughness of the composite were observed relative to
controls (Table 1).
Discussion
The goal of this study was to evaluate the long-term
biocompatibility of SWNTs in chondrocyte cultures for
potential use as a reinforcement material in hydrogel com-
posites for cartilage tissue engineering. Our findings indi-
cate that chondrocytes have a high tolerance for -COOH and
-PEG functionalized SWNTs, with minimal observed cyto-
toxicity in 3D culture systems (pellet and nanocomposite
constructs). In addition, functionalized SWNTs were found
to promote the expression of ECM proteins found in artic-
ular cartilage (at gene and protein levels) as well as improve
the mechanical properties of cell-laden constructs grown
over 5 weeks in culture.
In 2D cultures, chondrocytes experienced a dose-
dependent loss in viability in the presence of SWNT-
COOH or SWNT-PEG (Fig. 1), where low concentrations
of SWNTs were as benign as SM alone (Fig. 1), but higher
concentrations reduced viability of chondrocytes two- to
fourfold by D7. However, the behavior of chondrocytes in
2D can only be limitedly applicable to longer cultures, due
to the propensity of chondrocytes to dedifferentiate in this
environment.26 Moreover, in 2D cultures, SWNTs may
FIG. 2. Histological evalu-
ation of chondrocytes grown
in pellet culture with functio-
nalized SWNTs (-COOH or
-PEG) at 0.01 or 0.1 mg/mL
at day 14. (A–E) Alcian blue
staining, indicative of proteo-
glycan deposition; (F–J)
Picrosirius red staining,
indicative of collagen depo-
sition (scale bar = 50mm);
(K–M) SEM evaluation of
chondrocytes in pellet culture
in control or SWNT groups
(at 0.1 mg/mL). Color images
available online at www
.liebertpub.com/tea
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diffuse throughout the medium, increasing the potential for
endocytosis by cells, a phenomenon observed in other cell
types.27,28 Nevertheless, cell death was minimized by al-
tering both the SWNT dose and surface functionalization,
enabling greater than 80% viability up to D14 in 2D
culture. In 3D cultures, chondrocytes tolerated SWNTs at
higher concentrations than in 2D cultures, possibly because
the nanotubes are entrapped within the extracellular (pellet)
or hydrogel (composite) matrix, limiting their ability to be
absorbed by the cells. In addition, no marked changes in
the expression of oncogene Tp53 were seen in 3D culture
in SWNT groups relative to control, further confirming
their biocompatibility for cartilage tissue engineering appli-
cations.
The 3D culture duration (35 days) represents a signifi-
cantly longer culture time than previous reports examining
the effects of other types of nanotubes on the cellular re-
sponses of musculoskeletal cells.29,30 The presence of
SWNTs enhanced the deposition of GAGs in nanocompo-
sites, and cell pellets containing SWNT-COOH exhibited
comparable collagen deposition relative to control cultures.
These findings suggest that the presence of SWNTs in 3D
allows chondrocytes to maintain their ECM phenotype.
The presence of SWNT-COOH increased the compres-
sive biomechanical properties of nanocomposite scaffolds,
with temporal enhancement in EY and G* relative to control,
indicating functional enhancement of tissue-engineered
constructs. The significant increases in compressive EY
observed at D21 and D35 in culture are likely due to in-
creased GAG and other matrix deposition and their inter-
actions with SWNT-COOH, rather than due to SWNT
reinforcement of the hydrogel alone in compression. No
significant change in the compressive EY was observed in
SWNT groups relative to control at D0, before contribution
of de novo ECM deposition (Fig. 5B). We did not measure
changes in the tensile properties of SWNT composite hy-
drogels over the duration of the culture. However, our
findings on acellular samples suggest that an increase in the
tensile modulus and ultimate stress is indicative of a tensile
reinforcement of the nanocomposite scaffolds. These find-
ings are consistent with previous studies demonstrating that
single-wall or multiwall carbon nanotubes introduced into
synthetic biopolymers can improve the material properties
and strength of nanocomposite scaffolds.19,31 We hypothe-
size that the greater induction of de novo ECM deposition in
the SWNT-COOH composite group may result in better
tensile properties relative to the SWNT-PEG or control
groups, over time in culture, although future studies are
needed to confirm this hypothesis.
Our findings also point to a bimodal reinforcement of
both the compressive and tensile properties of hydrogels.
Changes in the ratio of tensile to compressive properties of
articular cartilage (and other multiphasic materials such as
hydrogels) may enhance the fluid load support, reduce
frictional properties, and consequently bolster the load-
bearing capability of native cartilage or tissue engineering
hydrogel materials.32,33 Although the mechanical proper-
ties of the SWNT-hydrogel composites remain below the
target properties of native articular cartilage,34,35 our
findings suggest that this nanocomposite material may
FIG. 3. Representative images of construct
morphology (A–C), live (D–F), dead (G–I),
and composite live/dead (J–L) staining at
day 7 of chondrocytes cultured in hydrogel-
SWNT nanocomposite scaffolds (scale bar=
50 mm). No significant change in construct
morphology or cell viability was observed at
D7 in culture in nanocomposite scaffolds at
0.01% w/v (0.1 mg/mL) SWNTs. Color
images available online at www.liebertpub
.com/tea
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bolster the mechanical properties of agarose hydrogels,
while maintaining optimal density and porosity needed
to maintain cellular viability and promote cartilaginous
growth.36,37
Surface coating of SWNTs was found to regulate the
biological responses of chondrocytes in 3D culture. The
carboxyl group (COOH) is a charged surface functional
group, which partly mimics the negative charges found in
PGs of cartilage (e.g., sulfate and carboxylic groups). Sur-
face coating with -COOH resulted in increased Col2a1 and
Fn gene expression throughout the culture in nanocomposite
scaffolds, indicative of increased chondrocyte metabolic
activity. In contrast, surface coating with neutral -PEG
moiety had no significant effect on Col2a1 or Fn gene ex-
pression, suggesting that the charged nature of the -COOH
surface functionalization may promote ECM expression in
this culture system. Increased expression may be a direct
effect of the chemical surface functionalization or may be
mediated by enhanced chemoelectrophysical regulation of
cells within a charged ECM, which may induce protein
regulation through resulting osmotic gradients or streaming
potentials.38,39
Regulation of Col2a1 and Fn1 expression in the -COOH
surface functionalized group may be occurring through al-
tered cell–matrix interactions in this model system. For
example, Col2 and Fn act as ligands for bl integrins in
chondrocytes.23,40–42 b1 integrins are responsible for chon-
drocyte adhesion to cartilage matrix and are involved in
mechanosensing and load-related changes in Agc1 and
matrix metalloproteinases.43,44 Although unexamined in this
study, we hypothesize that -COOH surface functionalization
may alter integrin expression or binding, potentially leading
FIG. 4. Quantitative PCR gene expression of chondrocytes cultured in Control (no SWNTs), 0.1 mg/mL SWNT-COOH,
or 0.1 mg/mL SWNT-PEG nanocomposite scaffolds up to 35 days in culture. Expression of (a) Agc, (b) Col2a1, (c)
Col10a1, (d) Col1a1, (e) Fn, (f) CD44, and (g) Tp53 was quantified (n = 3 per group, *p < 0.05 versus control, **p < 0.01
versus control, ***p < 0.001 versus control).
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to altered ligand expression or cell–matrix interactions.
Alternately, differential integrin activation (via a4b1, a5b1,
or avb3) by Fn domains may contribute to cell survival,
differentiation, or matrix remodeling.45–50 Thus, the obser-
vations demonstrated within may suggest a mechanism
wherein Fn or its fragments function in an autocrine manner
to promote the enhanced GAG content and EY observed
in the -COOH surface functionalized group. Further work
is required to demonstrate whether altered Fn1 expression in
-COOH surface functionalized groups concomitantly influ-
ences cognate integrin expression and whether this provides
an instructive signal toward chondrogenic phenotype and
matrix production.
Interestingly, Agc1 gene expression was not differen-
tially regulated in the -COOH versus -PEG groups (Fig. 4),
and composite constructs exhibited comparable GAG
content in both functionalization groups (Fig. 5A), sug-
gesting that surface functionalization with -COOH did not
upregulate all protein synthesis uniformly. A few studies
have examined the effects of surface functionalization of
nanotubes with peptides or proteins on cellular responses
in 2D and 3D (e.g.,10,51,52). Webster and colleagues have
developed an RGDSK (Arg-Gly-Asp-Ser-Lys) modified
rosette nanotube hydrogel composite for bone and cartilage
repair.30,53 They reported that modified nanotube hydro-
gels improve osteoblast and chondrocyte function and
improve cellular adhesion compared with hydrogel con-
trols. Our findings are consistent and expand upon these
studies, by highlighting the contribution of both surface
chemistry and biomimetic nanoscale properties toward
generating a cell favorable environment in nanocomposite
materials.30,53,54
The expression of CD44, a receptor for chondrocyte
binding with hyaluronan (HA), was found to significantly
increase in the control group over culture duration. This
increase may be associated with the observed increase in
GAG content, typically associated with increasing HA de-
position with time in culture. In nanocomposite scaffolds,
CD44 expression was significantly diminished relative to
control, independently of the surface functionalization.
Whereas GAG levels did increase over the duration of the
culture in SWNT groups, this increase was not associated
with increased CD44 expression. This may be due to po-
tentially lower ratios of HA relative to other GAGs in this
group. Alternatively, CD44 expression may be inhibited due
to the ultrastructural characteristics of the SWNT-hydrogel
nanocomposite. Previous studies have shown that chon-
drocytes respond to biomaterials early after implantation by
altering the expression of CD44 and bl integrins, as well as
ultrastructural characteristics.55 Whereas chondrocytes and
mesenchymal stem cells maintain CD44 expression when
cultured on HA-based scaffolds,56–58 it is unclear whether
CD44 expression in chondrocytes is maintained in non-HA-
based nano- or micromaterials.59,60
In conclusion, functionalized SWNTs promoted expression
of a chondrogenic ECM and improved the biomechanical
properties of cell-laden nanocomposites grown over 5 weeks
in culture. Surface coating of SWNTs with -COOH, but not
with -PEG, resulted in increased Col2a1 and Fn expression
throughout the culture in nanocomposite scaffolds, suggesting
that the charged nature of the -COOH surface functionaliza-
tion may be regulating the chondrocyte metabolic activity in
this culture system. The results of this study indicate that
FIG. 5. (A) Glycosaminoglycan (GAG) content (% of wet
weight) and (B) compressive material properties (Young’s
modulus) of nanocomposite scaffolds composed of control
(no SWNTs) or functionalized SWNT group (-COOH or
-PEG) at 0.1 mg/mL up to 35 days in culture (n= 4–6 per
group). ^p < 0.05 versus day 0 within group; *p< 0.05 versus
control at corresponding time point; +p < 0.05 versus PEG at
corresponding time point.
Table 1. Tensile Mechanical Properties of Acellular Nanocomposite Hydrogel– Functionalized
SWNTs at 0.1mg/ml
Modulus (kPa) Ultimate stress (kPa) Failure strain (%) Toughness (kPa)
Hydrogel 79.9 – 1.78 7.99 – 0.63 11.27 – 2.9 0.52 – 0.23
Hydrogel +SWNT-COOH 103.6 – 2.8 11.21 – 1.67 10.5 – 1.7 0.52 – 0.18
p-value 0.0002* 0.035* 0.721 0.978
Significant increases in the tensile modulus and ultimate stress were observed due to addition of SWNT-COOH (*p < 0.05). No significant
changes in the failure strain or toughness of samples were observed in the SWNT group versus control ( p > 0.5).
SWNTs, single-walled carbon nanotubes.
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SWNTs exhibit a unique potential for cartilage tissue engi-
neering, where functionalization with bioactive molecules
may provide an improved substrate for stimulation of cellular
growth and regeneration. Our findings complement the body
of literature demonstrating the efficacy of functionalized
SWNT nanocomposite scaffolds for repair, growth, and/or
regeneration of injured musculoskeletal tissues.20,21,61
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